Scancell signs agreement with Genmab
Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer and infectious…
Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer and infectious…
Oxford BioTherapeutics (OBT) says Genmab has licensed a novel antibody related to one of OBT's…
A biologics license application has been submitted to the US Food and Drug Administration (FDA)…
Here’s a list of the public European biotech companies that are worth more than a…
Stock markets worldwide have experienced painful instability in the last few months. As a result,…
The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for…
While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations…
As we enter 2021, the biotech industry is already bustling with activity. Here’s a list…
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
AbbVie and Genmab have announced a €3.4B collaboration deal that ranks as the second biggest…
Genmab, GeNeuro and other companies presented their latest data on next-generation treatments for multiple sclerosis…
The Danish biotech Genmab has made a big splash on the Nasdaq, raising a €450M…